gamma-Hydroxybutyric acid
- Generic Name
- gamma-Hydroxybutyric acid
- Brand Names
- Xywav
- Drug Type
- Small Molecule
- Chemical Formula
- C4H8O3
- CAS Number
- 591-81-1
- Unique Ingredient Identifier
- 30IW36W5B2
- Background
Gamma hydroxybutyric acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug; however GHB remains a Schedule I drug...
- Indication
Used as a general anesthetic, to treat conditions such as insomnia, clinical depression, narcolepsy, and alcoholism, and to improve athletic performance.
- Associated Conditions
- -
- Associated Therapies
- -
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
- Conditions
- Interventions
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06421532
Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder
- Conditions
- Interventions
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- Psychiatric University Hospital, Zurich
- Target Recruit Count
- 27
- Registration Number
- NCT04508166
- Locations
- 🇨ðŸ‡
University of Zurich, Zürich, Select An Option…, Switzerland
Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat
- Conditions
- Interventions
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-07-22
- Target Recruit Count
- 12
- Registration Number
- NCT04322214
- Locations
- 🇪🇸
José, Badalona, Barcelona, Spain
Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
- Conditions
- Interventions
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2022-05-12
- Lead Sponsor
- Erich Seifritz
- Target Recruit Count
- 54
- Registration Number
- NCT04082806
- Locations
- 🇨ðŸ‡
Psychiatric University Hospital, Zürich, ZH, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.